Țară: Țările de Jos
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
cefquinome 75 mg/ml
Intervet Deutschland GmbH
QJ01DE90
Suspension for injection
Cefquinome
Pigs Food
2012-03-21
Page 1 of 6 _[TEM-006 Version 01/2006] _ _ _ SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cobactan LA 7.5% w/v suspension for injection for swine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Cefquinome (as sulfate) 75 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection White to off-white resuspendable suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of swine respiratory disease (SRD) associated with _Actinobacillus _ _pleuropneumoniae, Haemophilus parasuis _and _Pasteurella multocida_ sensitive to cefquinome. 4.3 CONTRAINDICATIONS Do not use in animals which are known to be hypersensitive to cephalosporin antibiotics or to other β- lactam antibiotics, or to any of the excipients. Do not use in poultry (including eggs) due to risk of spread of antimicrobial resistance to humans. 4.4 SPECIAL WARNINGS In food borne pathogens, co-resistance can occur for various antimicrobial substances including aminoglycosides, sulphonamides and trimethoprim compounds, chloramphenicol, ciprofloxacin, gentamycin and tetracycline. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Cobactan LA 7.5% w/v suspension for injection for swine selects for resistant strains such as bacteria carrying extended spectrum betalactamases (ESBL) and may constitute a risk to human health if these strains disseminate to humans e.g. via food. For this reason, Cobactan LA 7.5% w/v suspension for injection for swine s Citiți documentul complet